Welcome to my portfolio site!
Here, I have organize my portfolio to make it easier for everone to look up about my professional and personal life.
Here you will find my CV, Blog, Location and contact. You can also find some of my favorite Photos.
Alright, lets start with a brief introduction.
My name is Mohammad Sharif Khan. Curretly, I am a senior research scientist at Cargill Core R&D. My area of expertise in on the volatile chemical analysis using state-of-art sampling and chromatography-mass spectrometry techniques. I have more than 8 years of experience on multidimentional gas chromaotgraphy, high resolution mass spectrometry, metabolomics, breath analaysis and bioinformatics.
Before I join at Cargill, I was a research fellow at Wake Forest Baptist Health, NC. My work at WFBH emphasis on the application of high-resolution omics techniques for the clinical application like volatile organic chemicals (VOCs) from breath to understand the mechanism for disease. I had developed a "breath model" for insuline resistence that provide the digonostics of metabolic disease before on-set of the clinical symptoms. I have worked toward the hypothesis-driven discovery, clinical validation, and clinical translation of biomarkers for the development of rapid, non invasive breath tests particularly for lung disease. And, incorporate high resolution mass spectral based -omics for pre-clinical, clinical model of disease.
Beofre I joined at Wake Forest, I worked at Dartmouth college as a research associate. My primary at Dartmouth emphesis on the biomarker discovery of the infectious disease like Tuberculosis (TB). My goal was to develop rapid, non-invasive, validated systems for TB diagnosis that can determine infection etiology, disease burden, and disease severity using the developed analytical methodologies.
I have worked with different collaborators and stakeholders to make some fruitful scientific collaborations already in my short career. I am an active member of the Royal Australian Chemical Institutes (RACI), American Chemical Society (ACS), and other organizations. I have collaborated with researchers from the USA, Italy, Japan, Thailand, Brazil, Malaysia, and Bangladesh and through this fellowship, would establish collaborations with researchers in South Africa. In 2018, my work was selected as “Outstanding research work by Australian Researchers” from ACS publication, highlighted on “LC-GC magazine” (2018) and nominated as the best work in the Capillary Chromatography conferences at Riva, Italy (2016). In 2018, I was awarded Monash publication award, Rector Fellowship at IIUM (2015) and Bronze medal at Malaysia Technology Expo in 2014. Recently, (2019), I was selected as a “Young Leader” at International Association of Breath Research (IABR).
My career aspiration is to be a leading researcher who builds and utilizes interdisciplinary collaborations and employ on infectious disease, tuberculosis, and ‘omics’ technology. I am committed to sharing my research findings with the all stakeholders, including patients, government, scientists, students, technologists, and the broader community. As I want to continue in academia, I will disseminate my acquired knowledge through publications, presentations at scientific meetings, as well as teaching students, who will serve the country in future.
Here, I have organize my portfolio to make it easier for everone to look up about my professional and personal life.
Here you will find my CV, Blog, Location and contact. You can also find some of my favorite Photos.
Alright, lets start with a brief introduction.
My name is Mohammad Sharif Khan. Curretly, I am a senior research scientist at Cargill Core R&D. My area of expertise in on the volatile chemical analysis using state-of-art sampling and chromatography-mass spectrometry techniques. I have more than 8 years of experience on multidimentional gas chromaotgraphy, high resolution mass spectrometry, metabolomics, breath analaysis and bioinformatics.
Before I join at Cargill, I was a research fellow at Wake Forest Baptist Health, NC. My work at WFBH emphasis on the application of high-resolution omics techniques for the clinical application like volatile organic chemicals (VOCs) from breath to understand the mechanism for disease. I had developed a "breath model" for insuline resistence that provide the digonostics of metabolic disease before on-set of the clinical symptoms. I have worked toward the hypothesis-driven discovery, clinical validation, and clinical translation of biomarkers for the development of rapid, non invasive breath tests particularly for lung disease. And, incorporate high resolution mass spectral based -omics for pre-clinical, clinical model of disease.
Beofre I joined at Wake Forest, I worked at Dartmouth college as a research associate. My primary at Dartmouth emphesis on the biomarker discovery of the infectious disease like Tuberculosis (TB). My goal was to develop rapid, non-invasive, validated systems for TB diagnosis that can determine infection etiology, disease burden, and disease severity using the developed analytical methodologies.
I have worked with different collaborators and stakeholders to make some fruitful scientific collaborations already in my short career. I am an active member of the Royal Australian Chemical Institutes (RACI), American Chemical Society (ACS), and other organizations. I have collaborated with researchers from the USA, Italy, Japan, Thailand, Brazil, Malaysia, and Bangladesh and through this fellowship, would establish collaborations with researchers in South Africa. In 2018, my work was selected as “Outstanding research work by Australian Researchers” from ACS publication, highlighted on “LC-GC magazine” (2018) and nominated as the best work in the Capillary Chromatography conferences at Riva, Italy (2016). In 2018, I was awarded Monash publication award, Rector Fellowship at IIUM (2015) and Bronze medal at Malaysia Technology Expo in 2014. Recently, (2019), I was selected as a “Young Leader” at International Association of Breath Research (IABR).
My career aspiration is to be a leading researcher who builds and utilizes interdisciplinary collaborations and employ on infectious disease, tuberculosis, and ‘omics’ technology. I am committed to sharing my research findings with the all stakeholders, including patients, government, scientists, students, technologists, and the broader community. As I want to continue in academia, I will disseminate my acquired knowledge through publications, presentations at scientific meetings, as well as teaching students, who will serve the country in future.
